Mds News - MDZ

Czura Thornton Announces Intention to Acquire Global Central Laboratory Business of MDS Pharma Services

LONDON, Oct. 9 /PRNewswire/ -- Private investment firm Czura Thornton today announced it has signed an agreement to acquire the global central...

MDS Nordion Selected One of Canada's Top 100 Employers for 2010

Strong Corporate Values, Employee Engagement and Contributions to the Community Make Company Exciting Place to Work OTTAWA, Oct. 9...

- Report of Foreign Issuer (6-K)

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule...

MDS Announces Agreement to Sell Central Labs Operation to Czura Thornton

TORONTO, Oct. 9 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life...

Leading Proxy Advisory Firms Recommend that MDS Shareholders Vote in Favour of the Divestiture of MDS Analytical Technologies

Risk Metrics Group, PROXY Governance, Inc., and Glass, Lewis & Co. Support Sale TORONTO, Oct. 8 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS;...

- Report of Foreign Issuer (6-K)

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16...

MDS Files Management Proxy Circular

Board Unanimously Recommends Shareholders Approve the Sale of MDS Analytical Technologies TORONTO, Sept. 24 /PRNewswire-FirstCall/ -- MDS Inc...

- Report of Foreign Issuer (6-K)

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16...

MDS Announces CEO Transition Plan

Steve West Appointed Chief Operating Officer and Future CEO TORONTO, Sept. 17 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a...

- Report of Foreign Issuer (6-K)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or...

- Statement of Beneficial Ownership (SC 13D)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of...

- Report of Foreign Issuer (6-K)

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16...

- Report of Foreign Issuer (6-K)

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16...

MDS Reports Third Quarter 2009 Financial Results

TORONTO, Sept. 10 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life...

- Amended Statement of Beneficial Ownership (SC 13D/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities and Exchange Act of...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Mds (MDZ)

Empower your portfolio: Real-time discussions and actionable trading ideas.

MDZ News

Czura Thornton Announces Intention to Acquire Global Central Laboratory Business of MDS Pharma Services

MDS Nordion Selected One of Canada's Top 100 Employers for 2010

- Report of Foreign Issuer (6-K)

MDS Announces Agreement to Sell Central Labs Operation to Czura Thornton

Leading Proxy Advisory Firms Recommend that MDS Shareholders Vote in Favour of the Divestiture of MDS Analytical Technologies

- Report of Foreign Issuer (6-K)

MDS Files Management Proxy Circular

- Report of Foreign Issuer (6-K)

MDS Announces CEO Transition Plan

- Report of Foreign Issuer (6-K)

- Statement of Beneficial Ownership (SC 13D)

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

MDS Reports Third Quarter 2009 Financial Results

- Amended Statement of Beneficial Ownership (SC 13D/A)

MDZ Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Mds (MDZ) News

Mds (MDZ)

Empower your portfolio: Real-time discussions and actionable trading ideas.

MDZ News

Czura Thornton Announces Intention to Acquire Global Central Laboratory Business of MDS Pharma Services

MDS Nordion Selected One of Canada's Top 100 Employers for 2010

- Report of Foreign Issuer (6-K)

MDS Announces Agreement to Sell Central Labs Operation to Czura Thornton

Leading Proxy Advisory Firms Recommend that MDS Shareholders Vote in Favour of the Divestiture of MDS Analytical Technologies

- Report of Foreign Issuer (6-K)

MDS Files Management Proxy Circular

- Report of Foreign Issuer (6-K)

MDS Announces CEO Transition Plan

- Report of Foreign Issuer (6-K)

- Statement of Beneficial Ownership (SC 13D)

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

MDS Reports Third Quarter 2009 Financial Results

- Amended Statement of Beneficial Ownership (SC 13D/A)

MDZ Discussion

Your Recent History